FDA Investigator Ashutosh Rao, PhD
Ashutosh Rao, PhD has conducted inspections on 4 sites in 2 countries as of 22 Oct 2018. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
22 Oct 2018
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Switzerland,
United States of America
FDA Investigators that have inspected at least one site in common with Ashutosh Rao, PhD:
Addam S Reynolds,
Adetutu M Gidado,
Amy Devlin, PhD,
Anastasia G Lolas,
Bo Chi, PhD,
Bonita S Chester,
Brandon C Heitmeier,
Charles Yuanchia Kuo, PhD,
Christopher Downey, PhD,
Daniel J Grabicki,
Devaughn Edwards,
Donald C Obenhuber, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Emmanuel Jramos Maldonado,
Frances Namuswe, PhD,
Frederick F Razzaghi,
Gerald B Seaborn, Jr,
Herbert M Corbello,
Ivis L Negron,
Jacek Cieslak, PhD,
Jason F Chancey,
Jee Chung, PhD,
Jorge L Guadalupe,
Juhong Liu, PhD,
Justine Tomasso,
Karishma G Gopaul,
Katherine Szestypalow,
Kevin A Gonzalez,
Kristy A Zielny,
Leopold Kong, PhD,
Leslie Arivera Rosado, PhD,
Libia M Lugo,
Madushini Dharmasena, PhD,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Maria Joselopez Barragan, PhD,
Mark W Babbitt,
Mary E Storch,
Mary Kaulee,
Meredith L Sheridan,
Meredith P Soehl, Investigator,
Michael Shanks, MS,
Nadeem I Chaudhry,
Nerizza B Guerin,
Nicholas A Violand,
Patricia F Hughes, PhD,
Paul L Bellamy,
Paula A Trost,
Penny H Mccarver,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Robert Rodriguez,
Russell J Glapion,
Santos E Camara,
Sean G Casey,
Seneca D Toms,
Simon Williams, PhD,
Sonya M Edmonds,
Steven Fong, MS, PhD,
Susan P Bruederle,
Tara G Bizjak,
Tara R Gooen,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Vaishali J Patel,
Veronica Fuentes, MS,
William Hallett, PhD,
Xiaokuang Lai, PhD,
Xiaoxiao Pan, PhD,
Xuhong Li,
Ying Xin Fan, PhD,
Young M Choi, PhD,
Yuan Chia Kuo,
Yun Wu, PhD,
Zhenzhen Liu, PhD,
Zhong Li, PhD
Ashutosh Rao, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2010 | FDA 483 | Renaissance Lakewood LLC - Form 483, 2010-04-01 |
April, 2010 | FDA 483 | Renaissance Lakewood LLC - Form 483, 2010-04-28 |
June, 2016 | EIR | Sarepta Therapeutics Inc - EIR, 2016-06-23 |
December, 2017 | FDA 483 | Lonza AG - Form 483, 2017-12-15 |
October, 2018 | FDA 483 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483, 2018-10-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more